Advertisement FDA approves Abbott's glucose monitoring system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Abbott’s glucose monitoring system

Abbott has said that the FDA has approved the FreeStyle Navigator continuous glucose monitoring system in the US for people with diabetes.

Designed to discretely and continuously measure glucose levels through a sensor in the back of the upper arm or abdomen, Abbott’s FreeStyle Navigator system is said ti provide minute-by-minute information about which way and how quickly blood sugar levels are changing. This information can lead to proactive adjustments that can result in tighter glucose ranges.

By measuring glucose levels continuously, the FreeStyle Navigator system is designed to provide more and better information than traditional fingerstick glucose measurements, which can lead to improved diabetes management. The FreeStyle Navigator system will be available in the second quarter of 2008 by prescription only.